Last reviewed · How we verify
Talion Tab
Talion Tab is a small molecule that inhibits the activity of a specific enzyme.
Talion Tab is a small molecule that inhibits the activity of a specific enzyme. Used for Type 2 diabetes.
At a glance
| Generic name | Talion Tab |
|---|---|
| Sponsor | Hanlim Pharm. Co., Ltd. |
| Drug class | SGLT2 inhibitor |
| Target | SGLT2 |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
By inhibiting this enzyme, Talion Tab reduces the production of a certain substance in the body, which is associated with the progression of the disease it is intended to treat.
Approved indications
- Type 2 diabetes
Common side effects
- Nausea
- Diarrhea
- Vomiting
Key clinical trials
- A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis (PHASE3)
- The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis (PHASE3)
- A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis (PHASE3)
- Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus (PHASE3)
- Repeated Dosing Clinical Trial of HL151 (PHASE1)
- Single Dosing Clinical Trial of HL151 (PHASE1)
- Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers (PHASE1)
- A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Talion Tab CI brief — competitive landscape report
- Talion Tab updates RSS · CI watch RSS
- Hanlim Pharm. Co., Ltd. portfolio CI